ArticleEuropean journal of pediatrics2025
The triglyceride glucose index as a biomarker for different glucose disorders in overweight and obese children and adolescents.
Article in European journal of pediatrics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
5 citing papers in PubMed.
- 20/ (fasting C-peptide × fasting plasma glucose) as a novel marker for insulin resistance in obese children and adolescents.Pediatric research · 2026Article
- Associations Between Nutritional Status, Cognitive Performance, and Surrogate Metabolic Profiles in School-Aged Children.Nutrients · 2026Article
- Evaluation of the triglyceride-glucose index, serum inflammatory biomarkers and lipid profile in patients with neovascular age-related macular degeneration.International ophthalmology · 2026Article
- Reduced circulating mitochondrial DNA integrity and increased DNA oxidation in preclinical and clinical pediatric obesity: an observational study.Frontiers in pediatrics · 2026Article
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The triglyceride/glucose index (TyG index), a formula derived from fasting triglyceride (TG) and glucose levels, has emerged as a simple and reliable alternative marker for estimating insulin resistance (IR). This study aimed to evaluate the potential utility of the TyG index in predicting different glucose disorders (GD) in obese and overweight children. This prospective study included 60 children aged 5 to 15 years with overweight or obesity. They were divided into two equal groups: Group 1 consisted of children with obesity (BMI > 95th percentile), and Group 2 comprised overweight children (BMI 85th-95th percentile). The control group consisted of 30 healthy children with normal BMI, matched for age and sex. TG, fasting blood glucose (FBG), oral glucose tolerance test, 2-h postprandial glucose, the TyG index, homeostatic model assessment for IR (HOMA-IR), and glycated hemoglobin (HbA1c) were measured in all participating children. TG, HbA1c, FBG, and the TyG index were significantly elevated in both groups 1 and 2 compared with the control group. There was a strong positive correlation between TyG index and (HbA1C, FBG, HOMA IR, and 2-h postprandial glucose). The TyG index demonstrated a strong predictive ability for type 2 diabetes, impaired glucose tolerance, impaired fasting glucose, and IR with cut-off values of 4.57, 4.52, 4.43, and 4.34, respectively. These cut-off values were associated with sensitivities of 100%, 100%, 88.9%, and 71.4%, and specificities of 95.3%, 95.1%, 88.3%, and 100%, respectively.
conclusionThe TyG index is a promising and reliable marker for detecting different glucose disorders in obese and overweight children. WHAT IS KNOWN: • The triglyceride/glucose index (TyG index), a formula derived from fasting triglyceride (TG) and glucose levels, has emerged as a simple and reliable alternative marker for estimating insulin resistance (IR) in pediatrics and adults. WHAT IS NEW: • We investigated, for the first time, the potential utility of the TyG index in predicting different glucose disorders (GD) such as type 2 diabetes mellitus (T2DM), impaired glucose tolerance, impaired fasting glucose as well as IR in obese and overweight children. • We found that the TyG index is a promising and reliable marker for detecting different glucose disorders in obese and overweight children.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.